|
Volumn 8, Issue 4, 2011, Pages 182-183
|
Testicular cancer: Is chemotherapy associated with cognitive impairment?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
ETOPOSIDE;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURVIVOR;
COGNITION;
COGNITIVE DEFECT;
DISEASE ASSOCIATION;
DISTRESS SYNDROME;
HUMAN;
MULTIPLE CYCLE TREATMENT;
ORCHIECTOMY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TESTIS CANCER;
CHEMICALLY INDUCED DISORDER;
MALE;
META ANALYSIS (TOPIC);
NEUROPSYCHOLOGICAL TEST;
NOTE;
PSYCHOLOGICAL ASPECT;
TESTIS TUMOR;
ANTINEOPLASTIC AGENTS;
COGNITION DISORDERS;
HUMANS;
MALE;
META-ANALYSIS AS TOPIC;
NEUROPSYCHOLOGICAL TESTS;
QUALITY OF LIFE;
TESTICULAR NEOPLASMS;
|
EID: 79953871653
PISSN: 17594812
EISSN: 17594820
Source Type: Journal
DOI: 10.1038/nrurol.2011.29 Document Type: Article |
Times cited : (11)
|
References (10)
|